Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.
Journal: Neuro-oncology advances
Published: October 13, 2022
Showing 1-2 of 2
Last Updated: 09/26/2026